Skip to main content
. Author manuscript; available in PMC: 2009 Feb 23.
Published in final edited form as: Surgery. 2008 Aug;144(2):239–244. doi: 10.1016/j.surg.2008.03.032

Fig 1.

Fig 1

Vasoreactivity of human skeletal muscle arterioles to the IK/SK channel activator, NS309. A, Dose-dependent relaxation of human skeletal muscle arterioles (n = 8) in response to NS309 pre- and post-CPB. *P < .05. B, Dose-dependent, NS309-mediated relaxation of pre-CPB human skeletal muscle arterioles pretreated in the absence or presence of TRAM34 and apamin (n = 6). **P < .001. C, Dose-dependent, NS309-mediated relaxation of pre-CPB human skeletal muscle arterioles (n = 6) with intact or denuded endothelium. **P < .001. Data are presented as percent relaxation after preconstriction with U46619.